{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/iqvia-iqv/",
 "dataUrl": "https://clearank.com/stock/iqvia-iqv/data.json",
 "title": "IQVIA Holdings (IQV) Stock Forecast & Price Target (2026)",
 "description": "IQVIA Holdings Inc. (IQV) stock: Healthcare, Diagnostics & Research. $44.4B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "IQVIA Holdings Inc. (IQV)",
 "published": "2026-07-29T09:16:24+00:00",
 "modified": "2026-09-16T02:41:01.864+00:00",
 "generated": "2026-09-16T12:02:24.356Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "IQV",
  "name": "IQVIA Holdings Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Diagnostics & Research",
  "country": "United States",
  "website": "https://www.iqvia.com"
 },
 "quote": {
  "price": 269.67,
  "previousClose": 265.67,
  "change": 4,
  "changePercent": 1.51,
  "open": 263.17001,
  "high": 272.35001,
  "low": 262.95001,
  "volume": 1439043,
  "averageVolume": 1351694,
  "marketCap": 44387683646,
  "fiftyTwoWeekHigh": 272.35001,
  "fiftyTwoWeekLow": 154.5,
  "marketOpen": false,
  "asOf": "2026-09-16T02:41:01.000Z"
 },
 "statistics": {
  "pe": 32.558456,
  "eps": 8.04,
  "dividendYield": 0,
  "beta": 1.186,
  "priceToSales": 2.5370865,
  "priceToBook": 6.9822087,
  "revenueTtm": 16983000064,
  "grossMargin": 0.328525641025641,
  "returnOnEquity": 0.22818
 },
 "technicals": {
  "rsi": 60.77,
  "macd": 7.82,
  "sma50": 237.67,
  "sma200": 203.06,
  "rsiSignal": "Bullish",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 75,
  "consensus": "Buy",
  "fairValue": 278,
  "analystTarget": 278,
  "analystCount": 21,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-16T02:41:01.000Z",
  "priceAtAnalysis": 269.67001,
  "volatility": {
   "daily": 1.69,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 264.28,
  "aggressiveEntry": 269.67,
  "stopLoss": 250.11,
  "stopLossPercent": 5.36,
  "targets": [
   277.49,
   290.7,
   303.92
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 196.42,
    "base": 297.09,
    "upside90th": 449.36
   },
   {
    "year": 2028,
    "downside10th": 182.31,
    "base": 327.3,
    "upside90th": 587.61
   },
   {
    "year": 2029,
    "downside10th": 176.09,
    "base": 360.58,
    "upside90th": 738.35
   },
   {
    "year": 2030,
    "downside10th": 173.64,
    "base": 397.24,
    "upside90th": 908.8
   },
   {
    "year": 2031,
    "downside10th": 173.49,
    "base": 437.64,
    "upside90th": 1103.95
   },
   {
    "year": 2032,
    "downside10th": 174.98,
    "base": 482.14,
    "upside90th": 1328.49
   },
   {
    "year": 2033,
    "downside10th": 177.73,
    "base": 531.16,
    "upside90th": 1587.39
   },
   {
    "year": 2034,
    "downside10th": 181.55,
    "base": 585.17,
    "upside90th": 1886.11
   },
   {
    "year": 2035,
    "downside10th": 186.31,
    "base": 644.67,
    "upside90th": 2230.78
   },
   {
    "year": 2036,
    "downside10th": 191.92,
    "base": 710.23,
    "upside90th": 2628.3
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "IQV Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$263.17",
    "Day Range": "$262.95 to $272.35",
    "Prev Close": "$265.67",
    "Volume": "1.44M",
    "52-Week Range": "$154.50 to $272.35",
    "Market Cap": "$44.39B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Valuation is broadly in line with sector peers (2% difference), suggesting fair market pricing relative to industry standards."
   ]
  },
  {
   "id": "financials",
   "title": "IQV Financial Performance",
   "text": [
    "Analysis: In the last 2 quarters, IQV beat estimates 2 times. However, the stock fell 2 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "IQV Analysis",
   "text": [
    "IQVIA Holdings Inc. (IQV) is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), indicating an uptrend. The Relative Strength Index (RSI) is at 60.77, classified as bullish, suggesting strong upward momentum. The Moving Average Convergence Divergence (MACD) is positive at 7.82, further reinforcing the bullish sentiment. Key support levels are indicated by the 50-day SMA at $237.67 and the 20-day EMA at $257.90. Resistance is suggested by the current price and potentially higher levels based on analyst targets. Volume has been slightly above average recently, supporting the current price action. The overall chart structure points towards continued upward potential, provided these technical levels hold.",
    "IQVIA Holdings Inc. (IQV) has demonstrated an ability to beat analyst EPS estimates, including a significant 81.82% surprise in the quarter to June 2026, suggesting operational efficiency.",
    "Over $52.6 million in insider sales have been recorded recently, indicating potential concerns from management regarding the stock's current valuation or future prospects.",
    "Analysts forecast continued revenue growth for IQVIA Holdings Inc. (IQV), with next-year revenue growth estimated at 6.00%, supporting the company's market position.",
    "IQVIA Holdings Inc. (IQV) is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), with a bullish RSI of 60.77 and positive MACD, suggesting favorable price action.",
    "IQVIA Holdings Inc. (IQV) is positioned for continued growth, with Wall Street analysts projecting next-year EPS growth of 11.5% and revenue growth of 6.00%. The median analyst price target of $278 suggests a modest upside from the current price, aligning with the stock's bullish technical indicators including trading above key moving averages and positive RSI and MACD readings. The company's strong return on equity of 22.82% further supports a positive outlook. Potential catalysts for upside include continued strong execution in its diagnostics and research segment and successful integration of any new business developments. Conversely, risks such as the high debt-to-equity ratio of 2.58 and the substantial recent insider selling could weigh on the stock. Any failure to meet elevated market expectations, as hinted at by the market's reaction to recent earnings, could lead to a downside correction."
   ],
   "lists": {
    "ProTips": [
     "Monitor insider selling activity closely, as over $52.6 million in sales have been reported recently, which could signal management concerns.",
     "The stock is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), indicating positive short-to-medium term momentum, but watch for any breaches of these support levels.",
     "Given the higher debt-to-equity ratio of 2.58 compared to sector peers, investors should assess the company's debt servicing capabilities and interest rate sensitivity."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Positive EPS Surprises in Recent Quarters",
     "text": "IQVIA Holdings Inc. (IQV) has demonstrated an ability to beat analyst EPS estimates, including a significant 81.82% surprise in the quarter to June 2026, suggesting operational efficiency.",
     "source": "Company Earnings Reports"
    },
    {
     "type": "Bearish",
     "title": "Significant Insider Selling Activity",
     "text": "Over $52.6 million in insider sales have been recorded recently, indicating potential concerns from management regarding the stock's current valuation or future prospects.",
     "source": "Insider Transaction Filings"
    },
    {
     "type": "Neutral",
     "title": "Continued Revenue Growth Projections",
     "text": "Analysts forecast continued revenue growth for IQVIA Holdings Inc. (IQV), with next-year revenue growth estimated at 6.00%, supporting the company's market position.",
     "source": "Analyst Estimates"
    },
    {
     "type": "Bullish",
     "title": "Strong Technical Momentum",
     "text": "IQVIA Holdings Inc. (IQV) is trading above its 50-day and 200-day moving averages ($237.67 and $203.06), with a bullish RSI of 60.77 and positive MACD, suggesting favorable price action.",
     "source": "Technical Analysis Data"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "IQVIA Holdings Inc. (IQV) presents a mixed valuation picture with a P/E ratio of 32.56, which is slightly above the Healthcare sector median of 31.9. However, its price-to-sales ratio of 2.54 is below the sector median of 3.7, suggesting potential value on a revenue basis. The company demonstrates strong profitability with an 8.10% net profit margin and a strong 22.82% return on equity, significantly outperforming the sector's median ROE of 6.9%. Growth efficiency is supported by a next-year EPS growth estimate of 11.5%. The company's balance sheet shows a debt-to-equity ratio of 2.58, which is higher than the sector average, indicating a greater reliance on debt financing. This leverage, combined with the P/E ratio, suggests that investors are pricing in significant future growth, which needs to be consistently delivered to justify the current valuation.",
    "IQVIA Holdings Inc. (IQV) reported a significant EPS surprise of 81.82% in the quarter to June 2026, with actual EPS of -$0.02 against an estimate of -$0.11, although the stock saw a slight decline of 0.03% on the news. Prior to this, the quarter to December 2025 also showed an EPS beat of 13.64%. The company's revenue growth was reported at 8.7%, and forward estimates suggest continued growth with next-year revenue growth projected at 6.00%.",
    "A primary risk for IQVIA Holdings Inc. (IQV) stems from significant insider selling, with over $52.6 million in sales reported recently, indicating potential concerns among management regarding future performance or valuation. The company's debt-to-equity ratio of 2.58 is notably higher than the sector average, increasing financial risk, especially if interest rates rise or earnings falter. Also, while recent earnings have shown positive surprises, the stock's negative reaction to the latest earnings report suggests that market expectations may be high and sensitive to any deviations."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "44.39B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "32.56"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "8.04"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "272.35"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "154.50"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Bullish SMA Cross Bullish Price vs SMA Bullish MACD Bullish Golden Cross in effect with the 50-day SMA ($237.67) above the 200-day SMA ($203.06), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Bullish",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "60.77"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "7.82"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "237.67"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "203.06"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.42",
    "Correlation with Nasdaq 100 (QQQ)": "+0.31",
    "Correlation with Bitcoin (BTC)": "+0.22",
    "Correlation with Gold (XAU)": "+0.02"
   }
  },
  {
   "id": "trade-plans",
   "title": "IQV Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (60.8) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$277.49",
    "TARGET 2": "$290.70",
    "TARGET 3": "$303.92",
    "STOP LOSS": "$250.11"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+1.50%",
    "Average Feb return": "-3.07%",
    "Average Mar return": "-3.23%",
    "Average Apr return": "+2.31%",
    "Average May return": "+2.12%",
    "Average Jun return": "+5.08%",
    "Average Jul return": "+9.76%",
    "Average Aug return": "+1.68%",
    "Average Sep return": "-3.88%",
    "Average Oct return": "+0.39%",
    "Average Nov return": "+3.87%",
    "Average Dec return": "+0.75%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.69%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in IQV in September 2016 would be worth about $34,882 today, compared with about $35,497 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IQV today could grow to about $26,337 by 2036 in the base case, with a bull case near $97,464 and a bear case around $7,117. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "IQV Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $397 for IQV by 2030 in the base case, from $270 today (1.5x over 4 years). The downside path ends near $174. These are outcomes of a Monte Carlo simulation run on IQV's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using IQV's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "IQV simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$196",
        "$297",
        "$449"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$182",
        "$327",
        "$588"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$176",
        "$361",
        "$738"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$174",
        "$397",
        "$909"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$173",
        "$438",
        "$1,104"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$175",
        "$482",
        "$1,328"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$178",
        "$531",
        "$1,587"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$182",
        "$585",
        "$1,886"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$186",
        "$645",
        "$2,231"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$192",
        "$710",
        "$2,628"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "TMO Thermo Fisher Scientific Inc. NYSE $635.29 +3.53%",
     "url": "https://clearank.com/stock/tmo-stock-analysis/"
    },
    {
     "text": "ILMN Illumina Inc. NASDAQ $222.36 +6.80%",
     "url": "https://clearank.com/stock/ilmn-stock-analysis/"
    },
    {
     "text": "MCK McKesson Corporation NYSE $899.56 -1.25%",
     "url": "https://clearank.com/stock/mck-stock-analysis/"
    },
    {
     "text": "MOH Molina Healthcare Inc. NYSE $206.99 -3.31%",
     "url": "https://clearank.com/stock/moh-stock-analysis/"
    },
    {
     "text": "UNH UnitedHealth Group Inc. NYSE $377.59 -1.55%",
     "url": "https://clearank.com/stock/unitedhealth-group-unh/"
    },
    {
     "text": "VEEV Veeva Systems Inc. NYSE $266.62 +0.36%",
     "url": "https://clearank.com/stock/veev-stock-analysis/"
    },
    {
     "text": "VKTX Viking Therapeutics, Inc. NASDAQ $29.95 -5.01%",
     "url": "https://clearank.com/stock/viking-therapeutics-vktx/"
    },
    {
     "text": "IDXX IDEXX Laboratories, Inc. NASDAQ $510.73 +0.23%",
     "url": "https://clearank.com/stock/idxx-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "VUG vs VOOG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vug-vs-voog/"
    },
    {
     "text": "COIN vs HOOD Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/coin-vs-hood/"
    },
    {
     "text": "QQQ vs SCHG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/qqq-vs-schg/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "IQV Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$52.6M",
    "Insiders": "14",
    "Avg Transaction": "$4.8M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in IQV",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Jun 15, 2018",
       "cells": [
        "CPP INVESTMENT BOARD PRIVATE HOLDINGS INC Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "9.3M",
        "$957.0M"
       ]
      },
      {
       "label": "Nov 30, 2017",
       "cells": [
        "CPP INVESTMENT BOARD PRIVATE HOLDINGS INC Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "7.5M",
        "$764.8M"
       ]
      },
      {
       "label": "Jun 15, 2018",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS INC Unknown",
        "Sell",
        "6.7M",
        "$691.8M"
       ]
      },
      {
       "label": "Jun 15, 2018",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS, INC. Unknown",
        "Sell",
        "6.7M",
        "$691.8M"
       ]
      },
      {
       "label": "Mar 8, 2019",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS, INC. Director",
        "Sell",
        "4.0M",
        "$569.5M"
       ]
      },
      {
       "label": "Nov 30, 2017",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS INC Director and Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "5.4M",
        "$552.8M"
       ]
      },
      {
       "label": "Nov 30, 2017",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS, INC. Director and Beneficial Owner of more than 10% of a Class of Security",
        "Sell",
        "5.4M",
        "$552.8M"
       ]
      },
      {
       "label": "Feb 13, 2020",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS, INC. Unknown",
        "Sell",
        "3.0M",
        "$492.3M"
       ]
      },
      {
       "label": "Jul 28, 2020",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS, INC. Unknown",
        "Sell",
        "2.9M",
        "$464.5M"
       ]
      },
      {
       "label": "Dec 4, 2018",
       "cells": [
        "TPG GROUP HOLDINGS SBS ADVISORS, INC. Unknown",
        "Sell",
        "3.6M",
        "$442.1M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=IQVIA+Holdings+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is IQVIA Holdings Inc.'s stock price forecast for 2030?",
   "answer": "IQVIA Holdings Inc.'s (IQV) stock price forecast for 2030, based on Monte Carlo simulations, projects a base case of $397.24, with a downside scenario at $173.64 and an upside scenario at $908.8. These are statistical outcomes, not guaranteed price targets."
  },
  {
   "question": "Is IQVIA Holdings Inc. stock a buy right now?",
   "answer": "IQVIA Holdings Inc. (IQV) is currently rated as a 'Buy' by Wall Street analysts, with a median price target of $278, suggesting a 3.1% upside from its current price of $269.67. The stock exhibits bullish technical indicators, including trading above key moving averages and a positive RSI."
  },
  {
   "question": "What are the main risks facing IQVIA Holdings Inc.?",
   "answer": "Key risks for IQVIA Holdings Inc. (IQV) include substantial insider selling totaling over $52.6 million, a high debt-to-equity ratio of 2.58 compared to the sector average, and potential market sensitivity to earnings results, as evidenced by the stock's reaction to recent reports."
  },
  {
   "question": "How does IQVIA Holdings Inc. compare to its sector averages?",
   "answer": "IQVIA Holdings Inc. (IQV) shows a P/E ratio of 32.56, slightly above the Healthcare sector median of 31.9, but its price-to-sales ratio of 2.54 is below the sector median of 3.7. The company's ROE of 22.82% significantly outperforms the sector median of 6.9%, while its debt-to-equity ratio of 2.58 is higher than the sector average."
  },
  {
   "question": "What is the recent earnings performance of IQVIA Holdings Inc.?",
   "answer": "IQVIA Holdings Inc. (IQV) recently reported a significant EPS surprise of 81.82% for the quarter ending June 2026. While the company has demonstrated positive EPS surprises in recent quarters, the stock experienced a minor decline following the latest earnings release."
  },
  {
   "question": "What is the outlook for IQVIA Holdings Inc. over the next 12 months?",
   "answer": "The outlook for IQVIA Holdings Inc. (IQV) is cautiously optimistic, supported by a 'Buy' consensus from analysts and positive technical indicators. The company is expected to continue its revenue growth trajectory, with next-year revenue growth estimated at 6.00%. However, significant insider selling and a high debt-to-equity ratio present notable risks that could impact performance."
  },
  {
   "question": "Are there any significant institutional holders or activist investors in IQVIA Holdings Inc.?",
   "answer": "While specific large institutional holders or activist investors are not detailed, the significant insider selling activity, totaling over $52.6 million, warrants close monitoring for any shifts in management sentiment or strategic direction."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "TMO",
    "name": "Thermo Fisher Scientific Inc. NYSE",
    "price": "$635.29",
    "change": "+3.53%",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   },
   {
    "ticker": "ILMN",
    "name": "Illumina Inc. NASDAQ",
    "price": "$222.36",
    "change": "+6.80%",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "MCK",
    "name": "McKesson Corporation NYSE",
    "price": "$899.56",
    "change": "-1.25%",
    "url": "https://clearank.com/stock/mck-stock-analysis/"
   },
   {
    "ticker": "MOH",
    "name": "Molina Healthcare Inc. NYSE",
    "price": "$206.99",
    "change": "-3.31%",
    "url": "https://clearank.com/stock/moh-stock-analysis/"
   },
   {
    "ticker": "UNH",
    "name": "UnitedHealth Group Inc. NYSE",
    "price": "$377.59",
    "change": "-1.55%",
    "url": "https://clearank.com/stock/unitedhealth-group-unh/"
   },
   {
    "ticker": "VEEV",
    "name": "Veeva Systems Inc. NYSE",
    "price": "$266.62",
    "change": "+0.36%",
    "url": "https://clearank.com/stock/veev-stock-analysis/"
   },
   {
    "ticker": "VKTX",
    "name": "Viking Therapeutics, Inc. NASDAQ",
    "price": "$29.95",
    "change": "-5.01%",
    "url": "https://clearank.com/stock/viking-therapeutics-vktx/"
   },
   {
    "ticker": "IDXX",
    "name": "IDEXX Laboratories, Inc. NASDAQ",
    "price": "$510.73",
    "change": "+0.23%",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "VUG vs VOOG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vug-vs-voog/"
   },
   {
    "ticker": "COIN vs HOOD Comparison",
    "name": "",
    "url": "https://clearank.com/compare/coin-vs-hood/"
   },
   {
    "ticker": "QQQ vs SCHG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/qqq-vs-schg/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "CCI",
    "text": "Crown Castle Inc.",
    "url": "https://clearank.com/stock/cci-stock-analysis/"
   },
   {
    "ticker": "AME",
    "text": "AMETEK, Inc.",
    "url": "https://clearank.com/stock/ame-stock-analysis/"
   },
   {
    "ticker": "VRSK",
    "text": "Verisk Analytics, Inc.",
    "url": "https://clearank.com/stock/vrsk-stock-analysis/"
   },
   {
    "ticker": "DEO",
    "text": "Diageo plc Sponsored",
    "url": "https://clearank.com/stock/deo-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "SBET",
    "text": "↓ 8.96%",
    "url": "https://clearank.com/stock/sharplink-sbet/"
   },
   {
    "ticker": "CAVA",
    "text": "↓ 8.93%",
    "url": "https://clearank.com/stock/cava-group-cava/"
   },
   {
    "ticker": "ARB/USD",
    "text": "↑ 19.42%",
    "url": "https://clearank.com/crypto/arbitrum-arb-usd/"
   },
   {
    "ticker": "INJ/USD",
    "text": "↓ 11.80%",
    "url": "https://clearank.com/crypto/injective-inj/"
   },
   {
    "ticker": "CRV/USD",
    "text": "↓ 11.53%",
    "url": "https://clearank.com/crypto/crv-usd-crypto-analysis/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "DHR",
    "text": "Danaher",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "IDXX",
    "text": "IDEXX",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   },
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "NTRA",
    "text": "Natera, Inc.",
    "url": "https://clearank.com/stock/natera-ntra/"
   },
   {
    "ticker": "TMO",
    "text": "Thermo Fisher",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/IQV-iqvia-holdings-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/IQV-iqvia-holdings-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "IQVIA Holdings (IQV) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/iqvia-iqv/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/iqvia-iqv/",
        "name": "IQVIA Holdings Inc. (IQV) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/iqvia-iqv/#webpage",
     "url": "https://clearank.com/stock/iqvia-iqv/",
     "name": "IQVIA Holdings (IQV) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-29T09:16:24+00:00",
     "dateModified": "2026-09-16T02:41:01+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/IQV-iqvia-holdings-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/iqvia-iqv/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/iqvia-iqv/#richSnippet",
     "headline": "IQVIA Holdings (IQV) Stock Forecast & Price Target (2026)",
     "name": "IQVIA Holdings (IQV) Stock Forecast & Price Target (2026)",
     "description": "IQVIA Holdings Inc. (IQV) stock: Healthcare, Diagnostics & Research. $44.4B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-07-29T09:16:24+00:00",
     "dateModified": "2026-09-16T02:41:01+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "IQVIA Holdings Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "IQV"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "IQVIA Holdings Inc. is a global healthcare services and analytics company that supports the life sciences industry with clinical research services, commercial insights, and healthcare intelligence. The company combines advanced data, technology solutions, and domain expertise to help pharmaceutical,",
      "tickerSymbol": "IQV",
      "sameAs": "https://www.iqvia.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/iqvia-iqv/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/IQV-iqvia-holdings-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/iqvia-iqv/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is IQVIA Holdings Inc.'s stock price forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "IQVIA Holdings Inc.'s (IQV) stock price forecast for 2030, based on Monte Carlo simulations, projects a base case of $397.24, with a downside scenario at $173.64 and an upside scenario at $908.8. These are statistical outcomes, not guaranteed price targets."
     }
    },
    {
     "@type": "Question",
     "name": "Is IQVIA Holdings Inc. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "IQVIA Holdings Inc. (IQV) is currently rated as a 'Buy' by Wall Street analysts, with a median price target of $278, suggesting a 3.1% upside from its current price of $269.67. The stock exhibits bullish technical indicators, including trading above key moving averages and a positive RSI."
     }
    },
    {
     "@type": "Question",
     "name": "What are the main risks facing IQVIA Holdings Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks for IQVIA Holdings Inc. (IQV) include substantial insider selling totaling over $52.6 million, a high debt-to-equity ratio of 2.58 compared to the sector average, and potential market sensitivity to earnings results, as evidenced by the stock's reaction to recent reports."
     }
    },
    {
     "@type": "Question",
     "name": "How does IQVIA Holdings Inc. compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "IQVIA Holdings Inc. (IQV) shows a P/E ratio of 32.56, slightly above the Healthcare sector median of 31.9, but its price-to-sales ratio of 2.54 is below the sector median of 3.7. The company's ROE of 22.82% significantly outperforms the sector median of 6.9%, while its debt-to-equity ratio of 2.58 is higher than the sector average."
     }
    },
    {
     "@type": "Question",
     "name": "What is the recent earnings performance of IQVIA Holdings Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "IQVIA Holdings Inc. (IQV) recently reported a significant EPS surprise of 81.82% for the quarter ending June 2026. While the company has demonstrated positive EPS surprises in recent quarters, the stock experienced a minor decline following the latest earnings release."
     }
    },
    {
     "@type": "Question",
     "name": "What is the outlook for IQVIA Holdings Inc. over the next 12 months?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The outlook for IQVIA Holdings Inc. (IQV) is cautiously optimistic, supported by a 'Buy' consensus from analysts and positive technical indicators. The company is expected to continue its revenue growth trajectory, with next-year revenue growth estimated at 6.00%. However, significant insider selling and a high debt-to-equity ratio present notable risks that could impact performance."
     }
    },
    {
     "@type": "Question",
     "name": "Are there any significant institutional holders or activist investors in IQVIA Holdings Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "While specific large institutional holders or activist investors are not detailed, the significant insider selling activity, totaling over $52.6 million, warrants close monitoring for any shifts in management sentiment or strategic direction."
     }
    }
   ]
  }
 ]
}